J. Kellum, N. Lameire, P. Aspelin, R. Barsoum, E. Burdmann, S. Goldstein, C. Herzog, M. Joannidis, A. Kribben, A. Levey, A. Macleod, R. Mehta, P. Murray, S. Naicker, S. Opal, F. Schaefer, M. Schetz, S. Uchino
2012.2.29Kidney International Supplements
tlooto Summary
This Clinical Practice Guideline is designed to provide information and assist decision-making and is not intended to define a standard of care, and should not be interpreted as prescribing an exclusive course of management.
Abstract
SECTION I: USE OF THE CLINICAL PRACTICE GUIDELINE This Clinical Practice Guideline document is based upon the best information available as of February 2011. It is designed to provide information and assist decision-making. It is not intended to define a standard of care, and should not be construed as one, nor should it be interpreted as prescribing an exclusive course of management. Variations in practice will inevitably and appropriately occur when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice. Every health-care professional making use of these recommendations is responsible for evaluating the appropriateness of applying them in the setting of any particular clinical situation. The recommendations for research contained within this document are general and do not imply a specific protocol.
Citation format
KELLUM, J., et al. Notice. Kidney International Supplements, 2012, 2: 1–1.